Anaplastic Thyroid Cancer Global Clinical Trials Review, H2, 2018

Publisher Name :
Date: 31-Oct-2018
No. of pages: 92
Inquire Before Buying

Anaplastic Thyroid Cancer Global Clinical Trials Review, H2, 2018

Summary

GlobalData's clinical trial report, "Anaplastic Thyroid Cancer Global Clinical Trials Review, H2, 2018" provides an overview of Anaplastic Thyroid Cancer clinical trials scenario. This report provides top line data relating to the clinical trials on Anaplastic Thyroid Cancer. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides a snapshot of the global clinical trials landscape

- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status

- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company

- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment

- The Report provides enrollment trends for the past five years

- Report provides latest news for the past three months

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

- Assists in formulating key business strategies with regards to investment

- Helps in identifying prominent locations for conducting clinical trials which saves time and cost

- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities

- Supports understanding of trials count and enrollment trends by country in global therapeutics market

- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials

- Facilitates clinical trial assessment of the indication on a global, regional and country level

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Anaplastic Thyroid Cancer Global Clinical Trials Review, H2, 2018

Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Report Guidance 5
GlobalData Clinical Trials Report Coverage 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 11
Top Five Countries Contributing to Clinical Trials in Europe 12
Top Countries Contributing to Clinical Trials in North America 13
Top Countries Contributing to Clinical Trials in Middle East and Africa 14
Top Countries Contributing to Clinical Trials in Central and South America 15
Clinical Trials by G7 Countries: Proportion of Anaplastic Thyroid Cancer to Oncology Clinical Trials 16
Clinical Trials by Phase in G7 Countries 18
Clinical Trials in G7 Countries by Trial Status 19
Clinical Trials by E7 Countries: Proportion of Anaplastic Thyroid Cancer to Oncology Clinical Trials 21
Clinical Trials by Phase in E7 Countries 23
Clinical Trials in E7 Countries by Trial Status 24
Clinical Trials by Phase 25
In Progress Trials by Phase 26
Clinical Trials by Trial Status 27
Clinical Trials by End Point Status 29
Subjects Recruited Over a Period of Time 30
Clinical Trials by Sponsor Type 31
Prominent Sponsors 32
Top Companies Participating in Anaplastic Thyroid Cancer Therapeutics Clinical Trials 34
Prominent Drugs 36
Clinical Trial Profile Snapshots 37
Appendix 90
Abbreviations 90
Definitions 90
Research Methodology 91
Secondary Research 91
About GlobalData 91
Contact Us 92
Disclaimer 92
Source 92

List of Tables
Anaplastic Thyroid Cancer Therapeutics, Global, Clinical Trials by Region, 2018* 7
Anaplastic Thyroid Cancer Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2018* 9
Anaplastic Thyroid Cancer Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2018* 10
Anaplastic Thyroid Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2018* 11
Anaplastic Thyroid Cancer Therapeutics Clinical Trials, Europe, Top Five Countries, 2018* 12
Anaplastic Thyroid Cancer Therapeutics Clinical Trials, North America, Top Countries, 2018* 13
Anaplastic Thyroid Cancer Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2018* 14
Anaplastic Thyroid Cancer Therapeutics Clinical Trials, Central and South America, Top Countries, 2018* 15
Proportion of Anaplastic Thyroid Cancer to Oncology Clinical Trials, G7 Countries (%), 2018* 17
Anaplastic Thyroid Cancer Therapeutics, G7 Countries, Clinical Trials by Phase, 2018* 18
Anaplastic Thyroid Cancer Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2018* 20
Proportion of Anaplastic Thyroid Cancer to Oncology Clinical Trials, E7 Countries (%), 2018* 22
Anaplastic Thyroid Cancer Therapeutics, E7 Countries, Clinical Trials by Phase, 2018* 23
Anaplastic Thyroid Cancer Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2018* 24
Anaplastic Thyroid Cancer Therapeutics, Global, Clinical Trials by Phase, 2018* 25
Anaplastic Thyroid Cancer Therapeutics, Global, Clinical Trials In Progress by Phase 2018* 26
Anaplastic Thyroid Cancer Therapeutics, Global, Clinical Trials by Trial Status, 2018* 28
Anaplastic Thyroid Cancer Therapeutics Clinical Trials, Global, by End Point Status, 2018* 29
Anaplastic Thyroid Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2013-2017 30
Anaplastic Thyroid Cancer Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2018* 31
Anaplastic Thyroid Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2018* 33
Anaplastic Thyroid Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2018* 35
Anaplastic Thyroid Cancer Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2018* 36

List of Figures
Anaplastic Thyroid Cancer Therapeutics, Global, Clinical Trials by Region (%), 2018* 7
Anaplastic Thyroid Cancer Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2018* 8
Anaplastic Thyroid Cancer Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2018* 10
Anaplastic Thyroid Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2018* 11
Anaplastic Thyroid Cancer Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2018* 12
Anaplastic Thyroid Cancer Therapeutics Clinical Trials, North America, Top Countries (%), 2018* 13
Anaplastic Thyroid Cancer Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2018* 14
Anaplastic Thyroid Cancer Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2018* 15
Proportion of Anaplastic Thyroid Cancer to Oncology Clinical Trials, G7 Countries (%), 2018* 16
Anaplastic Thyroid Cancer Therapeutics, G7 Countries, Clinical Trials by Phase, 2018* 18
Anaplastic Thyroid Cancer Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2018* 19
Proportion of Anaplastic Thyroid Cancer to Oncology Clinical Trials, E7 Countries (%), 2018* 21
Anaplastic Thyroid Cancer Therapeutics, E7 Countries, Clinical Trials by Phase, 2018* 23
Anaplastic Thyroid Cancer Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2018* 24
Anaplastic Thyroid Cancer Therapeutics, Global, Clinical Trials by Phase (%), 2018* 25
Anaplastic Thyroid Cancer Therapeutics, Global, Clinical Trials In Progress by Phase, 2018* 26
Anaplastic Thyroid Cancer Therapeutics, Global, Clinical Trials by Trial Status, 2018* 27
Anaplastic Thyroid Cancer Therapeutics Clinical Trials, Global, by End Point Status, 2018* 29
Anaplastic Thyroid Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2013-2017 30
Anaplastic Thyroid Cancer Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2018* 31
Anaplastic Thyroid Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2018* 32
Anaplastic Thyroid Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2018* 34
Anaplastic Thyroid Cancer Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2018* 36
GlobalData Methodology 91
  • 2015-2027 Global Pancreatic Cancer Industry Market Research Report, Segment by Player, Type, Application, Marketing Channel, and Region
    Published: 26-May-2020        Price: US 2960 Onwards        Pages: 127
    The worldwide market for Pancreatic Cancer is estimated to grow at a CAGR of roughly X.X% in the next 8 years, and will reach X.X million US$ in 2027, from X.X million US$ in 2020. The report covers market size status and forecast, value chain analysis, market segmentation of Top countries in Major Regions, such as North America, Europe, Asia-Pacific, Latin America and Middle East & Africa, by type, application and marketing channel. In addition, the report focuses on the driving ......
  • COVID-19 Impact on Melanoma Therapeutics Market, Global Research Reports 2020-2021
    Published: 21-May-2020        Price: US 3250 Onwards        Pages: 94
    This report covers market size and forecasts of Melanoma Therapeutics, including the following market information: - Global Melanoma Therapeutics Market Size, 2019-2021, and 2020 (quarterly data), (US$ Million) - Global Melanoma Therapeutics Market Size by Type and by Application, 2019-2021, and 2020 (quarterly data), (US$ Million) - Global Melanoma Therapeutics Market Size by Region (and Key Countries), 2019-2021, and 2020 (quarterly data), (US$ Million) - Global Mel......
  • 2015-2027 Global Circulating Tumor Cells Industry Market Research Report, Segment by Player, Type, Application, Marketing Channel, and Region
    Published: 19-May-2020        Price: US 2960 Onwards        Pages: 132
    The worldwide market for Circulating Tumor Cells is estimated to grow at a CAGR of roughly X.X% in the next 8 years, and will reach X.X million US$ in 2027, from X.X million US$ in 2020. The report covers market size status and forecast, value chain analysis, market segmentation of Top countries in Major Regions, such as North America, Europe, Asia-Pacific, Latin America and Middle East & Africa, by type, application and marketing channel. In addition, the report focuses on the dr......
  • Covid-19 Impact on Acute Lymphoblastic Leukemia Therapeutics Market, Global Research Reports 2020-2021
    Published: 19-May-2020        Price: US 3250 Onwards        Pages: 101
    This report covers market size and forecasts of Acute Lymphoblastic Leukemia Therapeutics, including the following market information: - Global Acute Lymphoblastic Leukemia Therapeutics Market Size, 2019-2021, and 2020 (quarterly data), (US$ Million) - Global Acute Lymphoblastic Leukemia Therapeutics Market Size by Type and by Application, 2019-2021, and 2020 (quarterly data), (US$ Million) - Global Acute Lymphoblastic Leukemia Therapeutics Market Size by Region (and Key Cou......
  • Global Immuno-Oncology Market Growth (Status and Outlook) 2020-2025
    Published: 18-May-2020        Price: US 3660 Onwards        Pages: 119
    According to this study, over the next five years the Immuno-Oncology market will register a 15.5% CAGR in terms of revenue, the global market size will reach $ 56450 million by 2025, from $ 31750 million in 2019. In particular, this report presents the global revenue market share of key companies in Immuno-Oncology business, shared in Chapter 3. This report presents a comprehensive overview, market shares and growth opportunities of Immuno-Oncology market by type, application, ke......
  • Covid-19 Impact on Non-Hodgkin Lymphoma Therapeutics Market, Global Research Reports 2020-2021
    Published: 15-May-2020        Price: US 3250 Onwards        Pages: 97
    This report covers market size and forecasts of Non-Hodgkin Lymphoma Therapeutics, including the following market information: - Global Non-Hodgkin Lymphoma Therapeutics Market Size, 2019-2021, and 2020 (quarterly data), (US$ Million) - Global Non-Hodgkin Lymphoma Therapeutics Market Size by Type and by Application, 2019-2021, and 2020 (quarterly data), (US$ Million) - Global Non-Hodgkin Lymphoma Therapeutics Market Size by Region (and Key Countries), 2019-2021, and 2020 (qu......
  • Breast Cancer Monoclonal Antibodies Market Research: Global Status & Forecast by Geography, Type & Application (2016-2026)
    Published: 14-May-2020        Price: US 2280 Onwards        Pages: 60
    Summary According to 99Strategy, the Global Breast Cancer Monoclonal Antibodies Market is estimated to reach xxx million USD in 2020 and projected to grow at the CAGR of xx% during the 2021-2026. The report analyses the global Breast Cancer Monoclonal Antibodies market, the market size and growth, as well as the major market participants. The analysis includes market size, upstream situation, market segmentation, market segmentation, price & cost and industry enviro......
  • Global Acute Lymphoblastic Leukemia Therapeutics Market Research Report 2020, Segment by Key Companies, Countries, Types, Applications and Forecast 2021 to 2026
    Published: 11-May-2020        Price: US 3200 Onwards        Pages: 169
    According to HJ Research's study, the global Acute Lymphoblastic Leukemia Therapeutics market is estimated to be valued at XX Million US$ in 2019 and is projected to reach XX Million US$ by 2026, expanding at a CAGR of XX% during the forecast period. The report on Acute Lymphoblastic Leukemia Therapeutics market provides qualitative as well as quantitative analysis in terms of market dynamics, competition scenarios, opportunity analysis, market growth, industrial chain, etc. In this study, 2019 ......
  • Actinic Keratosis Treatment Market Research: Global Status & Forecast by Geography, Type & Application (2016-2026)
    Published: 09-May-2020        Price: US 2280 Onwards        Pages: 45
    Summary According to 99Strategy, the Global Actinic Keratosis Treatment Market is estimated to reach xxx million USD in 2020 and projected to grow at the CAGR of xx% during the 2021-2026. The report analyses the global Actinic Keratosis Treatment market, the market size and growth, as well as the major market participants. The analysis includes market size, upstream situation, market segmentation, market segmentation, price & cost and industry environment. In additi......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs